GRANTS AND FUNDING

CARRA offers members various funding opportunities to further research that leverages the CARRA network and positively impacts the pediatric rheumatology scientific community and advances the CARRA mission. Additional information for the different grant opportunities, including the application instructions and templates are available below.


CARRA Publication Support Grant

This funding opportunity is available to researchers to support efforts required to bring existing data from collaborative research projects to publication.  New or early investigators are encouraged to apply and will be afforded special consideration.  

Details:

  • Up to 5 grants will be awarded in 2017.
  • The funding limit of each grant is $10,000.
  • A given investigator can only apply for one grant per year.
  • Preference will be given to research that is collaborative in nature and has used CARRA infrastructure.
  • Grants will be considered on a rolling basis until 5 are awarded: simply complete and submit your request within the 2017 calendar year
  • A project report is required upon completion of the project or end of project period, whichever occurs first.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting in 2018.


Instructions:

  • Complete the application template.
  • Sign the document (verified electronic signature allowed).
  • You will need to submit your application online. The online application submission link will be announced soon.
  • Applications will be reviewed by the CARRA Executive Committee
  • Notification will occur within 4 weeks of application submission.

Click here for the Publication Support Grant submission form.


CARRA Large Grant

This funding opportunity supports the development and publication of a clinical or translational project which will immediately impact research projects within CARRA or result in a larger collaborative grant that furthers the CARRA mission. New or early investigators are encouraged to apply and will be afforded special consideration.  A successful application may be for:

  • an all-inclusive clinical or translational research project; or
  • a pilot research project, that if successful, could lead to extramural funding

Preference will be given to submissions which are collaborative and leverage current CARRA network resources or will further develop the CARRA network.

Details:

  • A maximum of 2 grants will be awarded per year.
  • The funding limit of each grant is $50,000 total costs.
  • A given investigator can only apply for one large grant per year.
  • The first deadline is for the Letter of Intent (LOI). All LOIs are due by October 1, 2017. The submission deadline for the application is December 1, 2017. Late submissions will not receive funding consideration.
  • Funds will be provided to the awardee through a contract between the PI’s institution and CARRA with no more than 8% indirects.
  • The project period is one year from the date of award.
  • A project report is required upon completion of the project or end of project period, whichever occurs first.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting in 2018.
  • If there is an unexpended balance at the end of the project period, a statement from the PI detailing the project status and forward plan for completion is required. There is no requirement for an accounting statement or formal application for a no cost extension.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • This is a total costs award. If indirects are requested, they must be inclusive of the maximum funding amount of $50,000. Indirects may not exceed 8%.
  • If requested, CARRA generally accepts up to $25K for salary support with a larger amount considered only under special circumstances with adequate justification.

Instructions:

  • Complete a one-page LOI on institution letterhead by the due date indicated.  The LOI should be a one-page letter which summarizes your ultimate full proposal.  Contents should include the name of your institution and a short description and aims of the project involved.  You should also include how your project fits CARRA’s guidelines and funding interests. The LOI is for informational purposes only, and approval is not needed to proceed with the full application.
  • You will need to submit your LOI online. The online submission link will be announced soon. (Note: The LOI must be submitted in advance of the application, but no later than October 1, 2017)
  • Complete the application template.
  • Sign the document (verified electronic signature allowed).
  • You will need to submit your application online. The online application submission link will be announced soon. Submission deadline is December 1, 2017
  • Applications will be reviewed by a review committee appointed by the CARRA Steering Committee and may include ad hoc reviewers. The review committee recommendations will be provided to the Steering Committee for final approval.
  • Awardees will be notified in December 2017.

Click here for the CARRA Large Grant submission form.


CARRA Small Grant

This opportunity is available to support projects in development.  New or early investigators are encouraged to apply and will be afforded special consideration.  The research project can be a pilot, continuation of ongoing research, or other projects that move forward clinical or translational research that furthers the CARRA mission. Preference will be given to research that is collaborative in nature, which leverage current CARRA network resources and/or will further develop the CARRA network.

Details:

  • There is no prespecified number of grants available
  • The funding limit of each grant is $25,000 (Requests for a lesser amount are highly encouraged)
  • A given investigator can only apply for one grant per year.
  • There will be two rounds in 2017. The submission deadlines are June 1, 2017 and December 1, 2017.
  • Funds will be provided to the awardee through one of 2 mechanisms:

1)      By invoice for payment for materials or services in support of the funded project; or
2)      As an unrestricted grant provided as a lump sum to a sundry account used by the PI according to the project budget.

  • The project period is one year from the date of award.
  • A project report is required upon completion of the project or end of project period, whichever occurs first.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting in 2018.
  • If there is an unexpended balance at the end of the project period, a statement from the PI detailing the project status and forward plan for completion is required. There is no requirement for an accounting statement or formal application for a no cost extension.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • This is a total costs award. CARRA does not provide indirect costs for this small grant program.
  • This funding mechanism is not intended for projects that are already eligible/appropriate for extramural funding.

Instructions:

  • Complete the application template.
  • Sign the document (verified electronic signature allowed).
  • You will need to submit your application online. The online application submission link will be announced soon. Deadlines are June 1, 2017 for the early round, and December 1, 2017 for the late round.
  • Your submission will be reviewed by the chair and vice chair of the appropriate disease research committee who will prioritize submissions from the research group.  The disease group chair recommendations will be submitted to the CARRA executive committee for final funding determination.  Awards will be announced within 8 weeks. 
  • View the recipients of CARRA’s 2016 Small Grants.

Click here for the CARRA Small Grant submission form.


CARRA Research Associate Advisory Committee (RAAC) Scholarships for Professional Certification and Continuing Education

CARRA’s RAAC is offering 13 scholarships of up to $200 each to help supplement costs of completing or continuing SOCRA or ACRP certification for CARRA research coordinators.  Applications are reviewed on a rolling basis and each applicant can only receive funding once per fiscal year.

Applicants must be current CARRA Research Associate (coordinator) members. Applications are submitted at:  https://wiki.carragroup.org/display/RAAC/Funding+opportunities+for+CARRA+Coordinators.

If you have any questions, you can email Jennifer Woo, RAAC Chair, at [email protected].

Recipients of the CARRA Large Grant have been announced:

Andrea KnightAndrea Knight
$50,000 for her submission entitled “The Impact of Mental Health Disorders on Medication Adherence & Health Care Utilization in Youth with Lupus.”
Betsy Mellins  Vivian E. Saper
Betsy Mellins & Vivian Saper
$50,000 for their submission entitled “Clinical and translational investigation of parenchymal lung disease in sJIA: A planning grant.”


Recipients of the CARRA Publications Support Grants have been announced:

Emily von SchevenEmily von Scheven
For her submission entitled “A Pilot Study of Consensus Treatment Plans (CTPs) for Induction Therapy in Childhood Proliferative Lupus Nephritis cLN)”
Sarah Ringold
Sarah Ringold
For her submission entitled “Sequence of Medication Use in JIA”
Suzanne Li
Suzanne Li
For her 3 submissions entitled “Process paper on steps involved in working towards conducting comparative effectiveness studies in a rare disease,” “Initial results of the jLS CTP pilot study,” and “Clinical assessment tools for jLS.”

 

Recipients of the 2016 Cure JM Foundation/CARRA Research Grant have been announced:

Hanna Kim, MD
$25,000 over 1 year for her submission entitled “Novel Biomarkers associated with Disease Activity in JDM” in order to expand biomarker analysis to broad proteomic analysis, replacing cytokine analysis from her previous grant.
Claire Deakin, MD
$50,000 over 2 years for her submission entitled “Genetic Risk Factors in Juvenile Dermatomyositis” which will enable inclusion of North American samples to enhance the statistical power of her study.
James Jarvis, MD
$25,000 over 2 years for his submission entitled “Plasma Exosomes in Juvenile Dermatomyositis.”

Pediatric Rheumatology European Society Young Investigator Meeting Grant Awarded

The Early Investigator group is excited to announce that Sri Grevich, from Seattle Children’s Hospital, and Michael Ombrello, from the NIH, have been selected to receive travel grants to present their work at the Pediatric Rheumatology European Society Young Investigator Meeting in Genoa, Italy in September. Sri’s abstract is entitled “Oral Health and Anti-Citrullinated Peptide Antibodies in JIA”. Michael’s abstract is entitled “Genetic Architecture Distinguishes sJIA from Oligoarticular or Polyarticular JIA.”

During the PReS Young Investigator Meeting, Jay Mehta will also be giving a talk on the work that the CARRA Early Investigator group is doing. This is part of CARRA’s efforts to create productive relationships with other international pediatric rheumatology research organizations.

Cure JM Foundation 2016 Funding Opportunity
The Cure JM Foundation will fund research or educational awards in two different cycles in 2016. The vision of Cure JM includes increasing awareness of juvenile myositis and funding research in juvenile myositis that will ultimately lead to a cure. Proposals will be accepted through August 31st, 2016. Each cycle will fund a maximum of three different proposals for up to $50,000 each. 

All clinical and/or translational research proposals related to the field of juvenile myositis will be considered and scored solely on scientific merit, overall impact, and feasibility. Proposals that improve the education of new clinicians in the field or that create programs or materials that educate clinicians with a goal of reducing time to diagnosis will also be considered.

Pfizer provides grants for autoimmune and inflammatory disease research. Applications can be on basic research in the etiology of autoimmune and inflammatory diseases or clinical research. This program is available only to junior and senior investigators based in the United States. Awards can be up to a maximum of $150,000 each. Research projects are expected to be completed within two years. Larger grants may be considered depending on scope and merit of the proposal. Review the process and opportunities here.

NIAMS Research Funding

NIAID Research Funding

ACR REF Awards and Grants